Literature DB >> 13319018

Myleran therapy in malignant neoplastic disease; use of 1,4-dimethanesulfonyloxbutane with emphasis on chronic granulocytic leukemia.

G A HYMAN, A GELLHORN.   

Abstract

Entities:  

Keywords:  LEUKEMIA/therapy

Mesh:

Substances:

Year:  1956        PMID: 13319018     DOI: 10.1001/jama.1956.02970090070014

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  2 in total

1.  Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.

Authors:  F G HAYHOE; D KOK
Journal:  Br Med J       Date:  1957-12-21

2.  Busulphan in the treatment of chronic granulocytic leukaemia.

Authors:  J M BRIDGES; D M HAYES; M G NELSON
Journal:  Br J Cancer       Date:  1961-09       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.